Furthermore, in a rat model of chronic obstructive pulmonary disease, testosterone supplementation has been shown to inhibit the activation of NRF1 and p65 in lung epithelial cells, thereby reducing pulmonary inflammatory responses [43]. The gene discussed is NRF1; the disease is chronic obstructive pulmonary disease.